1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ONCONETIX INC
Onconetix Inc XNAS: ONCO
2.93 -0.07 (-2.33%)
19,886
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Onconetix Inc is on 05 Sep 2025 for the purpose of Onconetix Inc Annual General Meeting for 2025 See details


Insider Trading disclosures for Onconetix Inc

The latest disclosure was made by Timothy R. Ramdeen in Onconetix Inc where a trade of 618 Common Stock done was reported to US exchanges on Aug. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Timothy R. Ramdeen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2025 618 658 - 0 Common Stock
Timothy R. Ramdeen Director Other type of transaction at price $ 0.00 per share. 15 Aug 2025 39 40 - 0 Common Stock
Simon Tarsh Director Other type of transaction at price $ 0.00 per share. 15 Aug 2025 39 40 - 0 Common Stock
Simon Tarsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2025 618 658 - 0 Common Stock
Thomas Meier Director Other type of transaction at price $ 0.00 per share. 15 Aug 2025 39 39 - 0 Common Stock
Thomas Meier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2025 618 657 - 0 Common Stock
Andrew J. Oakley Director Other type of transaction at price $ 0.00 per share. 15 Aug 2025 20 20 - 0 Common Stock
Andrew J. Oakley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2025 618 638 - 0 Common Stock
Andrew J. Oakley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2025 1,709 1,709 - 0 Common Stock
Ralph Schiess Interim CEO, CSO 20 Dec 2024 177,462 673,365 - 0 Common Stock
Christian Bruhlmann Chief Strategy Officer 20 Dec 2024 177,462 611,372 - 0 Common Stock
Timothy R. Ramdeen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,477 - 0 Common Stock
Simon Tarsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,477 - 0 Common Stock
James Sapirstein Director 26 Sep 2024 3,318 3,477 - 0 Common Stock
Thomas Meier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,318 - 0 Common Stock
Ajit Singh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,396 - 0 Common Stock
Ralph Schiess Interim CEO & CSO 24 Sep 2024 489,160 495,903 - - Common Stock
Christian Bruhlmann Chief Strategy Officer 24 Sep 2024 428,010 433,910 - - Common Stock
Singh Ajit Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 3,125 3,125 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures